New Cancer Drug Shrinks Lung Tumors in 42% of Patients

A recently approved pancreatic cancer drug is showing remarkable promise for lung cancer patients, shrinking tumors in 42% of people who had already tried other treatments.

The early results offer hope to thousands living with limited treatment options.